“The company completed its de-bottlenecking/re-engineering project for its Ibuprofen manufacturing facilities at Barnala with project cost of Rs 24 crore and commenced the enhanced production from today,” the APIs (active pharmaceutical ingredient) producer said in its filing.
| Subscribe To Our Free Newsletter |
